Radius Health Announces Third Quarter 2019 Results and Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Radius Health (RDUS) Tops Q3 EPS by 38c; Raises FY19 Sales Outlook
November 5, 2019 4:25 PM ESTRadius Health (NASDAQ: RDUS) reported Q3 EPS of ($0.44), $0.38 better than the analyst estimate of ($0.82). Revenue for the quarter came in at $46.77 million versus the consensus estimate of $45.69 million.
I am very pleased with our continued strong performance with TYMLOS. We are on a path to make TYMLOS the treatment of choice for high... More
